Current status: Answered by Malcolm Chisholm on 6 June 2002
To ask the Scottish Executive whether it supports NHS boards in prescribing Cox-2 in accordance with existing guidelines from the Health Technology Board for Scotland.
The Executive welcomes the Health Technology Board for Scotland's Comment on the use of Cox II selective inhibitors. NHSScotland should take account of this advice and ensure that these treatments are made available to meet clinical need.